Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.

Parikh, S

Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. [electronic resource] - Clinical pharmacology and therapeutics Aug 2007 - 197-203 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

0009-9236

10.1038/sj.clpt.6100122 doi


Alkynes
Amodiaquine--analogs & derivatives
Antimalarials--metabolism
Aryl Hydrocarbon Hydroxylases--genetics
Benzoxazines--metabolism
Burkina Faso
Chromatography, High Pressure Liquid
Cyclopropanes
Cytochrome P-450 CYP2C8
Dose-Response Relationship, Drug
Drug Interactions
Enzyme Inhibitors--metabolism
Genotype
HIV Protease Inhibitors--metabolism
Humans
Lopinavir
Malaria, Falciparum--drug therapy
Models, Biological
Polymorphism, Genetic
Pyridines--metabolism
Pyrimidinones--metabolism
Pyrones--metabolism
Reverse Transcriptase Inhibitors--metabolism
Saquinavir--metabolism
Spectrophotometry, Ultraviolet
Sulfonamides
Treatment Outcome
Trimethoprim--metabolism